More rigorous randomized data are needed, which could be challenging in light of the drugs’ indication based on BMI.
Evidence from multiple trials shows semaglutide, known for weight loss and diabetes control, also reduces chronic inflammation through mechanisms not solely tied to fat loss. This anti-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results